Antibiotics Market Intelligence Report - Global Forecast to 2027

Antibiotics Market Intelligence Report - Global Forecast to 2027

The Global Antibiotics Market is projected to reach USD 53,955.79 million by 2027 from USD 37,250.93 million in 2021, at a CAGR 6.36% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Antibiotics Market size was estimated at USD 10,509.50 million in 2021 and expected to reach USD 11,131.11 million in 2022, at a CAGR 6.25% to reach USD 15,123.37 million by 2027.
• The Asia-Pacific Antibiotics Market size was estimated at USD 14,140.45 million in 2021 and expected to reach USD 15,078.21 million in 2022, at a CAGR 6.50% to reach USD 20,642.13 million by 2027.
• The Europe, Middle East & Africa Antibiotics Market size was estimated at USD 12,600.97 million in 2021 and expected to reach USD 13,366.04 million in 2022, at a CAGR 6.30% to reach USD 18,190.27 million by 2027.

Market Segmentation & Coverage:

The report on antibiotics identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the antibiotics to forecast the revenues and analyze the trends in each of the following sub-markets:

Action Mechanism:

• Cell Wall Synthesis Inhibitors
• DNA Synthesis Inhibitors
• Mycolic Acid Inhibitors
• Protein Synthesis Inhibitors
• RNA Synthesis Inhibitors

Drug Class:

• Aminoglycosides
• Carbapenem
• Cephalosporin
• Fluoroquinolone
• Macrolides
• Penicillin
• Sulfonamides

Spectrum:

• Broad-spectrum Antibiotics
• Narrow-spectrum Antibiotics

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Abbott Laboratories
• Akron Incorporated
• Amneal Pharmaceuticals LLC
• Astellas Pharma, Inc.
• Bausch Health Companies, Inc.
• Bayer AG
• Bristol-Myers Squibb Company
• Cadila Healthcare Ltd.
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• Johnson & Johnson
• KYORIN Holdings, Inc.
• LG Chem Ltd.
• Lupin Limited
• Melinta Therapeutics, Inc.
• Merck & Co., Inc.
• MerLion Pharmaceuticals GmbH
• Mylan N.V.
• Novartis International AG
• Pfizer Inc.
• Sanofi S.A.
• Shionogi & Co., Ltd.
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries Ltd.